Effects of tachyplesin on the regulation of cell cycle in human hepatocarcinoma SMMC-7721 cells

World J Gastroenterol. 2003 Mar;9(3):454-8. doi: 10.3748/wjg.v9.i3.454.

Abstract

Aim: To investigate the effects of tachyplesin on the cell cycle regulation in human hepatcarcinoma cells.

Methods: Effects of tachyplesin on the cell cycle in human hepatocarcinoma SMMC-7721 cells were assayed with flow cytometry. The protein levels of p53, p16, cyclin D1 and CDK4 were assayed by immunocytochemistry. The mRNA levels of p21(WAF1/CIP1) and c-myc genes were examined with in situ hybridization assay.

Results: After tachyplesin treatment, the cell cycle arrested at G0/G1 phase, the protein levels of mutant p53, cyclin D1 and CDK4 and the mRNA level of c-myc gene were decreased, whereas the levels of p16 protein and p21(WAF1/CIP1) mRNA increased.

Conclusion: Tachyplesin might arrest the cell at G0/G1 phase by upregulating the levels of p16 protein and p21(WAF1/CIP1) mRNA and downregulating the levels of mutant p53, cyclin D1 and CDK4 proteins and c-myc mRNA, and induce the differentiation of human hepatocacinoma cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antimicrobial Cationic Peptides*
  • Carcinoma, Hepatocellular / metabolism
  • Carcinoma, Hepatocellular / pathology*
  • Cell Cycle / drug effects*
  • DNA-Binding Proteins / pharmacology*
  • Humans
  • Immunohistochemistry
  • Liver Neoplasms / metabolism
  • Liver Neoplasms / pathology*
  • Peptides, Cyclic / pharmacology*
  • Tumor Cells, Cultured

Substances

  • Antimicrobial Cationic Peptides
  • DNA-Binding Proteins
  • Peptides, Cyclic
  • tachyplesin peptide, Tachypleus tridentatus